|

Albumin-paclitaxel Injection Clinical Trials

3 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • Fudan University1
  • Chinese PLA General Hospital1
  • Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1

Indications

  • Cancer3
  • Urachal Cancer1
  • Paget Disease, Extramammary1
  • Penile Cancer1
  • Testicular Cancer1

Other3 trials

Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
Phase 2
Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors.
Phase 1/2
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.